𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study

✍ Scribed by Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
66 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use in a large, national population‐based cohort study, the Norwegian Women and Cancer study (NOWAC). Exposure information was collected through postal questionnaires. Based on follow‐up of 30,118 postmenopausal women by linkage to national registers of cancer, deaths, and emigration we revealed 540 incident breast cancer cases between 1996 and 2004. Compared to never users of either drugs current use of HRT gave a significant (p = 0.002) higher risk of breast cancer in former OC users, RR = 2.45 (95% CI 1.92–3.12), than among never users of OCs, RR = 1.67 (1.32–2.12). Relative risk of current use of HRT was similar for estrogen only and combinations with progestin added in ever users of OCs. The increased risk of breast cancer in current HRT users with a history of former OC use could have potential great impact on postmenopausal breast cancer risk as the proportion of postmenopausal women with former OC use will continue to increase. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Hormone replacement therapy and incidenc
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study
✍ Kjersti Bakken; Elin Alsaker; Anne Elise Eggen; Eiliv Lund 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 2 views

## Abstract Increasing use of HRT over the last 2 decades could have contributed to the increasing incidence of cancer in women. Our aim was to investigate the relation between use of HRT and risk of hormone‐dependent cancers in a Norwegian cohort of women. The Norwegian Women and Cancer (NOWAC) st

Oral contraceptive use, hormone replacem
Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women
✍ Geoffrey C. Kabat; Anthony B. Miller; Thomas E. Rohan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract Evidence from epidemiologic studies suggests a possible role of exogenous and endogenous hormones in colorectal carcinogenesis in women. However, with respect to exogenous hormones, in contrast to hormone replacement therapy, few cohort studies have examined oral contraceptive use in re

Breast cancer and specific types of oral
Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study
✍ Vanessa Dumeaux; Elin Alsaker; Eiliv Lund 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 1 views

## Abstract The aim of our study was to examine the risk of breast cancer according to specific types of estrogens and progestagens in oral contraceptives (OCs) based on the prospective Norwegian Women and Cancer study (NOWAC). Between 1991–97 women aged 30–70 years were drawn at random from the ce

The association between oral contracepti
The association between oral contraceptive use and lobular and ductal breast cancer in young women
✍ Sarah J. Nyante; Marilie D. Gammon; Kathleen E. Malone; Janet R. Daling; Louise 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 1 views

## Abstract Recent reports indicate that the incidence of lobular breast cancer is increasing at a faster rate than ductal breast cancer, which may be due to the differential effects of exogenous hormones by histology. To address this issue, we examined whether the relationship between oral contrac

Hormone replacement therapy and the risk
Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening
✍ Ingemar Persson; Erik Thurfjell; Reinhold Bergström; Lars Holmberg 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 37 KB 👁 3 views

There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer